Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 944-948

  Isaka, Masanori ^a   Yasuda, Yoko ^a   Kozuka, Satoshi ^a   Taniguchi, Tooru ^a   Miura, Yutaka ^a   Matano, Keiko ^a   Goto, Norihisa ^b   Tochikubo, Kunio ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Adverse effects; Aluminium adsorbed tetunus toxoid; Aluminium non adsorbed tetanus toxoid; Immunoglobulin E; Recombinant cholera toxin B subunit (rCTB)

Indexed keywords

ALUMINUM; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN E ANTIBODY; RECOMBINANT VACCINE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADSORPTION; ALUMINUM; ANIMALS; ANTIBODY SPECIFICITY; CHOLERA TOXIN; CHOLERA VACCINES; FEMALE; IMMUNOGLOBULIN E; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; TETANUS TOXOID; VACCINES, SYNTHETIC;

EID: 0033605323     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00280-1     Document Type: Article

References (28)

1. Butler N.R., Voyce M.A., Burland W.L., Hilton M.L. Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants. British Medical Journal. 1:1969;663-666.
2. Frost L., Johansen P., Pedersen S., Veien N., Østergaard P.A., Nielsen M.H. Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts. Allergy. 40:1985;368-372.
3. White R.G., Coons A.H., Connolly J.M. Studies on antibody production. III. The alum granuloma. Journal of Experimental Medicine. 102:1955;73-82.
4. Erdohazi M., Newman R.L. Aluminium hydroxide granuloma. British Medical Journal. 3:1971;621-623.
5. Goto N., Akama K. Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid. Microbiology and Immunology. 26:1982;1121-1132.
6. Goto N., Akama K. Local histopathological reactions to aluminum-adsorbed tetanus toxoid. Naturwissenschaften. 71:1984;427-428.
7. Goto N., Kato H., Maeyama J., et al. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties. Vaccine. 15:1997;1364-1371.
8. Vassilev T.L. Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid. Allergy. 33:1978;155-159.
9. Mancino D., Ovary Z. Adjuvant effects of amorphous silica and of aluminium hydroxide on IgE and IgG1 antibody production in different inbred mouse strains. International Archives of Allergy and Applied Immunology. 61:1980;253-258.
10. Gupta R.K., Siber G.R. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals. 22:1994;53-63.
11. Veien N.K., Hattel T., Justesen O., Nørholm A. Aluminium allergy. Contact Dermatitis. 15:1986;295-297.
12. Cogné M., Ballet J.J., Schmitt C., Bizzini B. Total and IgE antibody levels following booster immunization with aluminum absorbed and nonabsorbed tetanus toxoid in humans. Annals of Allergy. 54:1985;148-151.
13. Mark A., Björksten B., Granström M. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine. 13:1995;669-673.
14. Isaka M., Yasuda Y., Kozuka S., et al. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit. Vaccine. 16:1998;1920-1926.
15. Yasuda Y., Matano K., Asai T., Tochikubo K. Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant. FEMS Immunology and Medical Microbiology. 20:1998;311-318.
16. Mota I., Wong D. Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization. Life Sciences (Part II). 8:1969;813-820.
17. Tamura S-I., Shoji Y., Hasiguchi K., Aizawa C., Kurata T. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine. 12:1994;1238-1240.
18. Marinaro M., Staats H.F., Hiroi T., et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. Journal of Immunology. 155:1995;4621-4629.
19. Tochikubo K., Isaka M., Yasuda Y., et al. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine. 16:1998;150-155.
20. Lycke N., Severinson E., Strober W. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation. Journal of Immunology. 145:1990;3316-3324.
21. Lycke N., Severinson E., Strober W. Molecular effects of cholera toxin on isotype differentiation. Immunologic Research. 10:1991;407-412.
22. Snider D.P., Marshall J.S., Perdue M.H., Liang H. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. Journal of Immunology. 153:1994;647-657.
23. Elson C.O., Ealding W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. Journal of Immunology. 133:1984;2892-2897.
24. Lycke N., Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology. 59:1986;301-308.
25. Clements J.D., Hartzog N.M., Lyon F.L. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine. 6:1988;269-277.
26. Sun J-B., Holmgren J., Czerkinsky C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proceedings of the National Academy of Sciences of the United States of America. 91:1994;10795-10799.
27. Tamura S-I., Hatori E., Tsuruhara T., Aizawa C., Kurata T. Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin. Vaccine. 15:1997;225-229.
28. Ichikawa Y., Yamagata H., Tochikubo K., Udaka S. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis. FEMS Microbiology Letters. 111:1993;219-224.